Insider Transactions in Q1 2022 at Lexicon Pharmaceuticals, Inc. (LXRX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2022
|
Lonnel Coats Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48,053
-7.58%
|
$96,106
$2.85 P/Share
|
|
Feb 28
2022
|
Lonnel Coats Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
197,343
+10.22%
|
-
|
|
Feb 28
2022
|
Jeffrey L Wade President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,773
-11.74%
|
$51,546
$2.85 P/Share
|
|
Feb 28
2022
|
Jeffrey L Wade President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
66,933
+10.02%
|
-
|
|
Feb 28
2022
|
Brian T Crum SVP, General Counsel & Secr. |
SELL
Payment of exercise price or tax liability
|
Direct |
15,059
-13.15%
|
$30,118
$2.85 P/Share
|
|
Feb 28
2022
|
Brian T Crum SVP, General Counsel & Secr. |
BUY
Exercise of conversion of derivative security
|
Direct |
40,880
+11.76%
|
-
|
|
Feb 28
2022
|
Kenneth B. Kassler Taub SVP, Regulatory & QA |
SELL
Payment of exercise price or tax liability
|
Direct |
13,241
-13.36%
|
$26,482
$2.85 P/Share
|
|
Feb 28
2022
|
Kenneth B. Kassler Taub SVP, Regulatory & QA |
BUY
Exercise of conversion of derivative security
|
Direct |
36,628
+12.17%
|
-
|
|
Feb 28
2022
|
Alan J Main EVP, Innov & Chem Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
19,756
-10.11%
|
$39,512
$2.85 P/Share
|
|
Feb 28
2022
|
Alan J Main EVP, Innov & Chem Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
54,650
+9.19%
|
-
|
|
Feb 28
2022
|
Kiernan Seth VP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,261
-27.42%
|
$16,522
$2.85 P/Share
|
|
Feb 28
2022
|
Kiernan Seth VP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,128
+34.11%
|
-
|
|
Feb 28
2022
|
Kristen Alexander VP, Finance and Accounting |
SELL
Payment of exercise price or tax liability
|
Direct |
3,337
-16.44%
|
$6,674
$2.85 P/Share
|
|
Feb 28
2022
|
Kristen Alexander VP, Finance and Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
11,300
+18.67%
|
-
|